AU3266097A - New devices intended for the transdermic administration of trimegestone - Google Patents

New devices intended for the transdermic administration of trimegestone

Info

Publication number
AU3266097A
AU3266097A AU32660/97A AU3266097A AU3266097A AU 3266097 A AU3266097 A AU 3266097A AU 32660/97 A AU32660/97 A AU 32660/97A AU 3266097 A AU3266097 A AU 3266097A AU 3266097 A AU3266097 A AU 3266097A
Authority
AU
Australia
Prior art keywords
trimegestone
new devices
devices intended
transdermic administration
transdermic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU32660/97A
Other versions
AU717335B2 (en
Inventor
Jean-Luc Dubois
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of AU3266097A publication Critical patent/AU3266097A/en
Application granted granted Critical
Publication of AU717335B2 publication Critical patent/AU717335B2/en
Assigned to AVENTIS PHARMA S.A. reassignment AVENTIS PHARMA S.A. Alteration of Name(s) in Register under S187 Assignors: HOECHST MARION ROUSSEL
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
AU32660/97A 1996-06-11 1997-06-10 New devices intended for the transdermic administration of trimegestone Ceased AU717335B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR96/07208 1996-06-11
FR9607208A FR2749586B1 (en) 1996-06-11 1996-06-11 NOVEL DEVICES FOR THE TRANSDERMAL ADMINISTRATION OF TRIMEGESTONE, THEIR PREPARATION METHOD AND THEIR APPLICATION AS MEDICAMENTS
PCT/FR1997/001023 WO1997047333A1 (en) 1996-06-11 1997-06-10 Novel devices for transdermal administering of trimegestone

Publications (2)

Publication Number Publication Date
AU3266097A true AU3266097A (en) 1998-01-07
AU717335B2 AU717335B2 (en) 2000-03-23

Family

ID=9492919

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32660/97A Ceased AU717335B2 (en) 1996-06-11 1997-06-10 New devices intended for the transdermic administration of trimegestone

Country Status (23)

Country Link
EP (1) EP0906127B1 (en)
JP (1) JP2000514416A (en)
CN (1) CN1110327C (en)
AR (1) AR013580A1 (en)
AT (1) ATE216269T1 (en)
AU (1) AU717335B2 (en)
BR (1) BR9709690A (en)
CA (1) CA2257902A1 (en)
CZ (1) CZ295227B6 (en)
DE (1) DE69712057T2 (en)
DK (1) DK0906127T3 (en)
ES (1) ES2173453T3 (en)
FR (1) FR2749586B1 (en)
HU (1) HU225034B1 (en)
IL (1) IL127281A0 (en)
NO (1) NO315149B1 (en)
PL (1) PL189533B1 (en)
PT (1) PT906127E (en)
RU (1) RU2204417C2 (en)
TR (1) TR199802578T2 (en)
TW (1) TW474826B (en)
WO (1) WO1997047333A1 (en)
ZA (1) ZA975168B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2782635B1 (en) * 1998-08-27 2001-09-14 Oreal AEROSOL DEVICE CONTAINING A POLYCONDENSATE COMPRISING AT LEAST ONE POLYURETHANE AND / OR POLYUREA PATTERN
ITMI20020798A1 (en) * 2002-04-15 2003-10-15 F T Holding S A SILICONE ADHESIVE MATERIAL TRANSDERMAL PATCHES STABILIZED WITH METHACRYLIC COPOLYMERS
CN100457064C (en) * 2003-10-28 2009-02-04 诺芬药品公司 Transdermal drug delivery systems
US20070212402A1 (en) * 2003-12-05 2007-09-13 Rooven Qainton V Patch
JP2006230930A (en) * 2005-02-28 2006-09-07 Alcare Co Ltd Pasting material
CA2548864C (en) 2005-06-06 2012-12-11 Nitto Denko Corporation Percutaneous absorption-type pharmaceutical preparation
US7879942B2 (en) 2006-10-05 2011-02-01 Eastman Chemical Company Switchable adhesive article for attachment to skin and method of using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430953A1 (en) * 1978-07-13 1980-02-08 Roussel Uclaf NOVEL 3,20-DIOXO 4,9-DIENE 21-HYDROXYL DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
US4883669A (en) * 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
AU601528B2 (en) * 1986-12-22 1990-09-13 Ortho-Mcneil Pharmaceutical, Inc. Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers
US5186939A (en) * 1987-04-23 1993-02-16 Cygnus Therapeutic Systems Laminated composite for transdermal administration of fentanyl
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
DE4309830C1 (en) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Transdermal patches for oestradiol admin. - contg. isopropylidene mono- or di-glycerol as penetration enhancer
DE4405899A1 (en) * 1994-02-18 1995-08-24 Schering Ag Agent for transdermal application containing desogestrel

Also Published As

Publication number Publication date
DE69712057T2 (en) 2002-10-02
IL127281A0 (en) 1999-09-22
EP0906127A1 (en) 1999-04-07
DE69712057D1 (en) 2002-05-23
NO985791D0 (en) 1998-12-10
CZ410798A3 (en) 1999-09-15
WO1997047333A1 (en) 1997-12-18
HUP9903340A3 (en) 2000-04-28
FR2749586A1 (en) 1997-12-12
BR9709690A (en) 1999-08-10
FR2749586B1 (en) 1998-08-07
HUP9903340A2 (en) 2000-03-28
CN1110327C (en) 2003-06-04
ES2173453T3 (en) 2002-10-16
NO985791L (en) 1999-02-11
AR013580A1 (en) 2001-01-10
TR199802578T2 (en) 1999-03-22
HU225034B1 (en) 2006-05-29
AU717335B2 (en) 2000-03-23
CZ295227B6 (en) 2005-06-15
CA2257902A1 (en) 1997-12-18
NO315149B1 (en) 2003-07-21
DK0906127T3 (en) 2002-08-05
CN1227503A (en) 1999-09-01
ATE216269T1 (en) 2002-05-15
JP2000514416A (en) 2000-10-31
TW474826B (en) 2002-02-01
ZA975168B (en) 1998-07-22
PL189533B1 (en) 2005-08-31
PL330535A1 (en) 1999-05-24
PT906127E (en) 2002-09-30
EP0906127B1 (en) 2002-04-17
RU2204417C2 (en) 2003-05-20

Similar Documents

Publication Publication Date Title
AU2109195A (en) Two-component device for the administration of drugs
AU2839997A (en) Medical devices
EP0795342A3 (en) Disconnect for medical access devices
AU5402296A (en) Pharmaceutical composition for transdermic administration
AU4232596A (en) Peelable laminate
AU3532195A (en) Medicaments
AU3616295A (en) Pharmaceutically active substituted aromatic compounds
AU3802493A (en) Surgical endoclip
AU4477597A (en) New pharmaceutically active compounds
AU1690399A (en) Neovascularization inhibitor containing dienogest as the active ingredient
AU5136998A (en) Medicinal composition
AUPM740594A0 (en) Anti-inflammatory preparation
AU1774097A (en) Pharmaceutical compositions for the treatment of rhinitis
AU3350697A (en) Steroid bisphosphonates
AU3453897A (en) Medicinal cyclosporin-a aerosol solution formulation
AU3266097A (en) New devices intended for the transdermic administration of trimegestone
AU3460897A (en) Medicinal compositions
AU4636396A (en) Antiglucocorticoid medicament
AU4143397A (en) New pharmaceutically active compounds
AU9462498A (en) Hysteromyoma remedy containing dienogest as the active ingredient
AU5657494A (en) New steroids
AU5416898A (en) Cisplatinum comprising pharmaceutical
AU4362097A (en) Syringe for medicinal purposes
AU4142197A (en) Phase monitor
AU5959494A (en) Vaccines against sterols

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: AVENTIS PHARMA S.A.

Free format text: FORMER OWNER WAS: HOECHST MARION ROUSSEL